---
title: "688238.SH (688238.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688238.SH/news.md"
symbol: "688238.SH"
name: "688238.SH"
parent: "https://longbridge.com/en/quote/688238.SH.md"
datetime: "2026-03-11T09:01:27.052Z"
locales:
  - [en](https://longbridge.com/en/quote/688238.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688238.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688238.SH/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/688238.SH/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/688238.SH/news.md)


# 688238.SH (688238.SH) — Related News

### [Junshi Biosciences Chairman Buys 100,000 Shares Under Planned Stake Increase](https://longbridge.com/en/news/278649704.md)
*2026-03-11T03:13:23.000Z*
> Junshi Biosciences Chairman Buys 100,000 Shares Under Planned Stake Increase

### [Junshi receives China’s NMPA acceptance for toripalimab injection](https://longbridge.com/en/news/278544178.md)
*2026-03-10T10:43:55.000Z*
> Junshi Biosciences has received acceptance from China's NMPA for its toripalimab injection (JS001sc), the first domestic

### [Junshi Biosciences' Chair Boosts Shareholding](https://longbridge.com/en/news/275463354.md)
*2026-02-10T13:01:16.000Z*
> Junshi Biosciences' Chair Boosts Shareholding

### [OBiO Tech issued a profit warning, expecting a net loss attributable to the parent company of RMB 195 million to RMB 237 million in 2025](https://longbridge.com/en/news/273819228.md)
*2026-01-27T09:20:03.000Z*
> OBiO Tech expects a net loss attributable to the parent company of RMB 195 million to RMB 237 million in 2025, a decreas

### [OBiO Tech: Continuously deepening the exploration and application of new technologies to fully empower the company's business development](https://longbridge.com/en/news/266868714.md)
*2025-11-21T07:50:49.000Z*
> OBiO Tech (688238) held a performance briefing for the third quarter of 2025 on November 21, where key members of the ma

### [OBiO Tech has reached a full-chain strategic cooperation in the field of cells with Duozheng Biotechnology](https://longbridge.com/en/news/266643329.md)
*2025-11-20T01:06:11.000Z*
> According to OBiO Tech, on November 19th, OBiO Tech officially signed a strategic cooperation agreement with Changsha Du

### [OBiO Tech: Net loss of 105 million yuan in the first half of 2025, a year-on-year narrowing](https://longbridge.com/en/news/253423824.md)
*2025-08-18T08:59:16.000Z*
> OBiO Tech announced that its operating revenue in the first half of 2025 was 120 million yuan, a year-on-year increase o

### [OBiO Tech plans to promote a restricted stock incentive plan of 3.7454 million shares](https://longbridge.com/en/news/246430701.md)
*2025-06-27T12:45:06.000Z*
> According to the Zhitong Finance APP, OBiO Tech disclosed its 2025 Restricted Stock Incentive Plan (draft), proposing to

### [Zhengzhou Airport Economic Zone in Henan and OBiO Tech have strategic cooperation plans to build a "cell factory" and pilot the development of the cell gene therapy industry](https://longbridge.com/en/news/244618247.md)
*2025-06-16T02:46:01.000Z*
> According to reporters from the Zhengzhou Airport Economic Zone Management Committee in Henan, recently, the Management